Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health economic evaluation of a nurse-assisted online eye screening in home healthcare to reduce avoidable vision impairment (iScreen): study protocol for a cluster randomized controlled trial.
Rooth V, van der Aa H, Wisse RPL, Maarsingh OR, Koopmanschap M, Keunen JEE, Vermeulen H, Klaver CCW, Janssen G, van Rens GHMB, van Nispen RMA. Rooth V, et al. Among authors: keunen jee. Trials. 2024 Feb 2;25(1):102. doi: 10.1186/s13063-023-07882-0. Trials. 2024. PMID: 38308377 Free PMC article.
Grand Challenges in global eye health: a global prioritisation process using Delphi method.
Ramke J, Evans JR, Habtamu E, Mwangi N, Silva JC, Swenor BK, Congdon N, Faal HB, Foster A, Friedman DS, Gichuhi S, Jonas JB, Khaw PT, Kyari F, Murthy GVS, Wang N, Wong TY, Wormald R, Yusufu M, Taylor H, Resnikoff S, West SK, Burton MJ; Grand Challenges in Global Eye Health study group. Ramke J, et al. Lancet Healthy Longev. 2022 Jan;3(1):e31-e41. doi: 10.1016/S2666-7568(21)00302-0. Lancet Healthy Longev. 2022. PMID: 35028632 Free PMC article.
EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Feenstra HMA, Hahn LC, van Rijssen TJ, Tsonaka R, Breukink MB, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Fauser S, Hoyng CB, van Dijk EHC, Boon CJF. Feenstra HMA, et al. Among authors: keunen jee. Retina. 2022 Apr 1;42(4):721-729. doi: 10.1097/IAE.0000000000003363. Retina. 2022. PMID: 34864802 Clinical Trial.
RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Place Trial Report No. 4.
van Rijssen TJ, Hahn LC, van Dijk EHC, Tsonaka R, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, Keunen JEE, MacLaren RE, Querques G, Fauser S, Downes SM, Hoyng CB, Boon CJF. van Rijssen TJ, et al. Among authors: keunen jee. Retina. 2021 Oct 1;41(10):2122-2131. doi: 10.1097/IAE.0000000000003157. Retina. 2021. PMID: 34543244 Clinical Trial.
Phenotypic Consequences of the GJD2 Risk Genotype in Myopia Development.
Haarman AEG, Enthoven CA, Tedja MS, Polling JR, Tideman JWL, Keunen JEE, Boon CJF, Felix JF, Raat H, Geerards AJM, Luyten GPM, van Rijn GA, Verhoeven VJM, Klaver CCW. Haarman AEG, et al. Among authors: keunen jee. Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):16. doi: 10.1167/iovs.62.10.16. Invest Ophthalmol Vis Sci. 2021. PMID: 34406332 Free PMC article.
Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.
van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Dijkman G, Peters PJH, Tsonaka R, Keunen JEE, MacLaren RE, Hoyng CB, Downes SM, Fauser S, Boon CJF. van Rijssen TJ, et al. Among authors: keunen jee. Acta Ophthalmol. 2021 Nov;99(7):805-811. doi: 10.1111/aos.14775. Epub 2021 Feb 10. Acta Ophthalmol. 2021. PMID: 33565230 Free PMC article. Clinical Trial.
75 results